- Kevin Capatch, Director Process Engineering, Geisinger Health System
- Mike Schiller, CMRP, Senior Director of Supply Chain, American Hospital Association & AHRMM
- Tracy Nasarenko, Senior Director of Community Engagement, Healthcare, GS1 US
Regulation impacts both medical devices and pharmaceutical drugs in the U.S. as it does across the world. The U.S. FDA’s Unique Device Identification (UDI) Rule is aimed to identify medical devices sold in the United States from manufacturing through distribution to patient use. Similarly, the Drug Supply Chain Security Act (DSCSA) has its final milestone November of this year which will require item-level serialized traceability in an interoperable manner across the US pharmaceutical industry. Tracy Nasarenko, senior director of community engagement, healthcare, GS1 US is joined by Kevin Capatch, director process engineering, Geisinger Health System and Mike Schiller, CMRP, senior director of supply chain, American Hospital Association & AHRMM to uncover how global data standards for product identification support the industry to meet these regulatory requirements while providing a window into product inventory, orders, location, usage, and end of life, all in real time. The visibility benefits all stakeholders in the healthcare system—delivering operational efficiencies, inventory control, and course, the ultimate gain - patient safety by enabling faster, accurate, efficient removal of product when they expire or if they are recalled.